Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Y-shape pegylated somatropin[1] Somatotropin---[1] 78
2YAM80----[1] 2
3Yarrowia lipolytica lipase----[1] 298
4Yellow fever vaccine[1] Yellow fever vaccine[1] D06347 --[8] 40, 44, 46, 50, 51, 52, 53, 107
5Yellow Fever vaccine (17D)[1] Yellow fever vaccine[1] D06347 --[8] 40, 44, 46, 50, 51, 52, 53, 107
6Yisaipu[1] Yisaipu---[2] 46, 271
7Yisaipu®[1] Yisaipu---[1] 271
8YISAIPU® ( An etanercept biosimilar)[2] Etanercept,
Yisaipu		[1] D00742 [2] LTA,
TNF 💬		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
9YLB113----[1] 46
10YM672----[1] 226
11YM672 (IPD®)----[1] 226
12Yohimbine[1] Yohimbine[1] D08685 [3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6
13Yohimbine HCl[1] Yohimbine[1] D08685 [3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6
14Yondelis[1] Trabectedin[1] D06199 --[1] 159
15YONDELIS 0,25 mg polvo para concentrado para solución para perfusión[1] Trabectedin[1] D06199 --[1] 159
16Yondelis 0.25 mg powder for concentrate for solution for infusion.[1] Trabectedin[1] D06199 --[1] 159
17YONDELIS 1 mg polvo para concentrado para solución para perfusión[1] Trabectedin[1] D06199 --[1] 159
18Yondelis 1 mg powder for concentrate for solution for infusion.[1] Trabectedin[1] D06199 --[1] 159
19YRA-1909 high dose----[1] 46
20YRA-1909 low dose----[1] 46
21YRA-1909 mid dose----[1] 46
22Yttrium-90[1] Yttrium Y-90---[1] 28
23Yttrium-90 radiolabelled anti-CD66 antibody[1] Yttrium Y-90---[1] 28
24Yttrium­90 radiolabelled anti­CD66[1] Yttrium Y-90---[1] 28
25Yu-Shen formula----[1] 224
26Yuxuebi tablet----[1] 271